China and India spend just 3% of GDP on healthcare, as against 16% in the US, but that figure is set to grow far faster than in developed markets, says Andy Acker of Janus Capital.
Tag : pharma
In the US equity market, Scott Glasser of ClearBridge Advisors recommends increasing exposure to pharmaceuticals and cutting allocations to the energy sector, among other things.
Can Cipla do for bird flu what it has already done for Aids?